Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

B Riley FBR

Concerned About The Election? Take Profits Off The Table Now, Strategist Says
Concerned About The Election? Take Profits Off The Table Now, Strategist Says
Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race
Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race
Mastercraft Boat Rides Upgrade After Analyst Is 'Increasingly Confident' Demand Is Intact
Mastercraft Boat Rides Upgrade After Analyst Is 'Increasingly Confident' Demand Is Intact
Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race
Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race
Mastercraft Boat Rides Upgrade After Analyst Is 'Increasingly Confident' Demand Is Intact
Mastercraft Boat Rides Upgrade After Analyst Is 'Increasingly Confident' Demand Is Intact
Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development
Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development
Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone
Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone

B Riley FBR Recent News

The Midterm Election: What 3 Pros Expect
The Midterm Election: What 3 Pros Expect
Recent Assembly Biosciences Weakness Provides Attractive Entry Point, B Riley FBR Says In Upgrade
Recent Assembly Biosciences Weakness Provides Attractive Entry Point, B Riley FBR Says In Upgrade
FBR: Novavax Looks Healthy Ahead Of Catalysts
FBR: Novavax Looks Healthy Ahead Of Catalysts
Analysts React To Weight Watcher's Q2 Earnings
Analysts React To Weight Watcher's Q2 Earnings
Pluristem Therapuetics, Rexahn Pharma Are Biotech Winners, B Riley FBR Says In Bullish Initiation
Pluristem Therapuetics, Rexahn Pharma Are Biotech Winners, B Riley FBR Says In Bullish Initiation
Columbia Sportswear Downgraded Ahead Of Q2 Print
Columbia Sportswear Downgraded Ahead Of Q2 Print
Broadcom Shares Plummet After Wall Street Questions Sudden Acquisition Strategy
Broadcom Shares Plummet After Wall Street Questions Sudden Acquisition Strategy
Analyst: Tetra Technologies Is An 'EBITDA Engine'
Analyst: Tetra Technologies Is An 'EBITDA Engine'
Analyst Downgrades Arbutus Biopharma On Valuation After 80% Run
Analyst Downgrades Arbutus Biopharma On Valuation After 80% Run
3 Reasons Why Uniqure Could Overtake Hemophilia B Virus Gene Therapy
3 Reasons Why Uniqure Could Overtake Hemophilia B Virus Gene Therapy
Deciphera Pharma Hit With Sell-Side Downgrade On Valuation After 50% Gain
Deciphera Pharma Hit With Sell-Side Downgrade On Valuation After 50% Gain
HomeStreet Cost Cuts Should Result In Higher 2019 Earnings, Analyst Says In Upgrade
HomeStreet Cost Cuts Should Result In Higher 2019 Earnings, Analyst Says In Upgrade
Analysts Applaud Intel's Q1 Beat-And-Raise, Say Delay In 10-Nanometer Chips A Negative
Analysts Applaud Intel's Q1 Beat-And-Raise, Say Delay In 10-Nanometer Chips A Negative
Analyst: Clementia Has Potential To Reach Unmet Market For Rare Bone Disease
Analyst: Clementia Has Potential To Reach Unmet Market For Rare Bone Disease
Dicerna Pharma Has Multiple Pipeline Opportunities, Tough Competition, Analyst Says In Neutral Initiation
Dicerna Pharma Has Multiple Pipeline Opportunities, Tough Competition, Analyst Says In Neutral Initiation
Main Street Capital Has The Ingredients For Superior Economic Return, Says B Riley FBR
Main Street Capital Has The Ingredients For Superior Economic Return, Says B Riley FBR
JD Sports' $588-Million Finish Line Purchase Is Positive For Both Companies
JD Sports' $588-Million Finish Line Purchase Is Positive For Both Companies
BB&T Should Trade At Premium To Other Large-Cap Banks, Says B Riley FBR
BB&T Should Trade At Premium To Other Large-Cap Banks, Says B Riley FBR
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved